← Embedded Finance Index 2026

CancerFax

Can a small, founder-led navigator become the trusted bridge that routes global cancer patients to advanced therapies (CAR-T, gene therapy, trials) in China, India, and other emerging oncology hubs?

Founded2019
HQKolkata, India (with offices in Beijing, Hyderabad, Hong Kong, Romania, Cambodia)
FoundersSandeep Kumar Wamne
IndustryHealthcare / Medical Travel Facilitator
The story

CancerFax was founded in 2019 in India as a cross-border cancer treatment facilitator, initially connecting Indian patients to advanced therapies. It expanded to become a global oncology navigator with particular strength in India-China treatment pathways for CAR-T, gene therapy, and clinical trial access. The company operates as a marketplace/facilitator (not a medical provider), monetizing paid concierge services (case management, visa, interpretation, second opinions) and hospital referrals. It is a small operation (nine full-time staff) owned by Syncare Corporation, and is also the authorized distributor of Aletha Health Inc. physiotherapy products.

Last 12 months
2026-04
2026
Product timeline
2019
CancerFax founded in India by Sandeep Kumar Wamne after losing his sister to Non-Hodgkin lymphoma· founding
2020
First global expansion· expansion
2022
Entry into China and Singapore markets· expansion
2023
Crossed 1,000 patients guided· milestone
2024
CAR-T therapy access at scale· product
2025
Global presence achieved across 15+ countries· expansion
2026
Launched NGS Testing and Gene Therapy access in India· product
The stack
0 layers disclosed in CancerFax’s embedded-finance stack
Accounting gap: none